Inotiv · 5 days ago
Study Director II, Toxicology
Inotiv is a growing contemporary drug discovery and development company, and they are seeking a Study Director II in Toxicology. The role involves overseeing all phases of protocol development, supervising technical staff, and ensuring compliance with regulatory guidelines while maintaining the integrity of preclinical studies.
BiopharmaLife ScienceMedical DevicePharmaceutical
Responsibilities
Responsible for all phases of protocol development; communicating with supervisory staff to establish a study schedule, the sponsor to finalize the protocol and the technical staff to coordinate study initiation
Direct and/or supervise the work of technical staff in accordance with the GLP’s
Monitor the progress of studies and after consultation with senior staff, report the results to the sponsor
Participate in in-house training programs for the technical staff
Conduct literature and/or Internet searches in support of protocol or report preparation
With the assistance of senior staff, prepare posters and/or scientific paper that will contribute to the scientific reputation of Inotiv Evansville and the individual
In consultation with senior staff, prepare reports, papers and/or charts of study data for interim reports to the sponsor
Maintain knowledge of FDA and other regulatory guidelines that may affect protocol development
Inform the management of any issues affecting the conduct of preclinical studies, interaction with clients and/or generation of protocols and reports
Perform other duties as assigned
Maintain confidential information
Interact with the community and employees
Support and participate in other company initiatives as directed by management
Qualification
Required
Ability to read, write, speak, and understand English
Ability to read, write and understand oral and/or written instructions
Ability to read, write and interpret scientific material
Manual dexterity to perform research functions, type and use office equipment
Ability to stand or sit for long period of time
Frequent involvement with radiant/electrical energy, solvents, grease, oil, irritants, acids, bases, and other hazardous chemicals, electro-mechanical hazards, flammable materials, and biohazards
Due to exposure to hazardous biological materials (which may include HIV positive specimens), immunization to diseases may be required
Able to wear latex gloves, dust mask and/or respirator, and safety glasses as required
The noise level is usually moderate to loud requiring ear protection
Mantoux TB test with negative result is required
This position requires a bachelor's degree and 10 years of relevant experience, or a master's degree and 5 years relevant experience, or a doctoral degree in one of the biological sciences and at least 2 years relevant laboratory animal experience
Good organizational skills
Ability to use a computer to compile and maintain databases for records and inventory, utilizing the appropriate software
Know and understand cGMP/GLP/GCP and OECD regulations, as applicable, with the ability to apply these practices daily
Ability to work independently
Good written and oral communication skills
Ability to adhere to all safety regulations and procedures
Ability to document analytical results
Benefits
Health and dental coverage
Short- and long-term disability
Paid time off
Paid parental leave
401K
And more!
Company
Inotiv
Inotiv provides biopharmaceutical analytical, reproductive toxicology, medical device testing, DMPK, consulting and pathological services.
H1B Sponsorship
Inotiv has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (1)
2024 (1)
2023 (2)
2022 (1)
Funding
Current Stage
Public CompanyTotal Funding
$27.64MKey Investors
Indiana Economic Development Corporation
2024-12-18Post Ipo Equity· $27.6M
2022-06-20Grant· $0.04M
1997-11-28IPO
Recent News
2025-12-13
Company data provided by crunchbase